steroid therapy
- Generic Name
- steroid therapy
Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
Phase 1
Recruiting
- Conditions
- Acute Graft Versus Host DiseaseHematopoietic and Lymphoid System Neoplasm
- Interventions
- First Posted Date
- 2022-07-05
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- City of Hope Medical Center
- Target Recruit Count
- 18
- Registration Number
- NCT05443425
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
REMASTer: REcurrent Brain Metastases After SRS Trial
Not Applicable
Recruiting
- Conditions
- Brain MetastasesRadiation NecrosisRecurrent TumorRecurrent Metastases
- Interventions
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Monteris Medical
- Target Recruit Count
- 261
- Registration Number
- NCT05124912
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸UCLA, Los Angeles, California, United States
🇺🇸University of Maryland, Baltimore, Maryland, United States
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer
Phase 3
Completed
- Conditions
- Adenocarcinoma of the Gastroesophageal JunctionEsophageal CancerGastric CancerNausea and VomitingPain
- First Posted Date
- 2009-09-17
- Last Posted Date
- 2013-08-07
- Target Recruit Count
- 320
- Registration Number
- NCT00978549
- Locations
- 🇬🇧
Addenbrooke's Hospital, Cambridge, England, United Kingdom
🇬🇧St. Luke's Cancer Centre at Royal Surrey County Hospital, Guildford, England, United Kingdom
🇬🇧Medical Research Council Clinical Trials Unit, London, England, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath